BEN vs LAB · P/E 36, rev $8.77B vs rev $174.4M
Franklin Resources Inc (BEN) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Franklin Resources Inc (BEN) is a asset management company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported BEN revenue for 2025-09-30 was $8.77B. Net income was $548.9M. BEN currently screens at market cap $13.09B and trailing P/E 35.6.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
BEN currently screens at market cap $13.09B and trailing P/E 35.6. LAB currently screens at market cap $317.1M.
Not investment advice. Open the BEN and LAB stock pages for the full models.
Not investment advice.